Status:
COMPLETED
Impact of OSA on Outcomes in Acute Coronary Syndrome
Lead Sponsor:
MetroHealth Medical Center
Conditions:
OSA
ACS - Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Elucidating the effects of obstructive sleep apnea (OSA) on cardiovascular outcomes in acute coronary syndrome (ACS) is crucial in risk assessments and therapeutic recommendations for affected individ...
Detailed Description
Obstructive sleep apnea (OSA) is very common in middle aged adults. Using a polysomnography (PSG) derived definition, defined as an apnea hypopnea index (AHI) of \>5, it occurs in 20-30 % of males and...
Eligibility Criteria
Inclusion
- Patients presenting with:
- Acute coronary syndrome, including:
- ST segment elevation (STEMI)
- non-ST segment elevation (NSTEMI)
- unstable angina
- Who undergo coronary revascularization at our tertiary care center .
Exclusion
- Pregnancy
- Post-cardiac arrest patients
- Diagnosis of medical conditions associated with predicted survival of \< 6 months
- Need for tracheostomy and prolonged mechanical ventilation
- Prior treatment for sleep disordered breathing and unavailable sleep data
Key Trial Info
Start Date :
August 29 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
128 Patients enrolled
Trial Details
Trial ID
NCT03793582
Start Date
August 29 2017
End Date
December 31 2019
Last Update
December 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MetroHealth Medical Center
Cleveland, Ohio, United States, 44109